Genoscience Pharma is committed to serving the needs of patients, families, and physicians by providing rapid access to the developed innovative therapeutic treatment. The following is the list of the current investigational programs now in progress at Genoscience Pharma. Also listed below are the diseases targeted by our investigational programs.
Clinical Programs Now in Development at Genoscience Pharma
- Phase 1/2a study to evaluate the safety, activity, and pharmacokinetics of escalating doses of GNS561 in patients with advanced primary liver cancer
Diseases Targeted by the Investigational Programs
- Hepatocellular carcinoma
- Intra-hepatic cholangiocarcinoma